More specifically, we aimed to evaluate the association between DPYD mutational status and incidence of 5-FU-related adverse events, such as mucositis, as well as the associated consequences of dysphagia, pharyngolaryngeal pain, and aspiration pneumonia. This evidence concerns the gene DPYD and mucositis.